Corporate Development
CurrentInvolved in Corporate Development / M&A activities aimed at commercialization of innovative healthcare diagnostics systems developed by Scope Fluidics. In 2022, Scope Fluidics sold a quick PCR system to Bio-Rad Laboratories for USD >100m. My responsibilities covered coordinating the communication and due diligence with potential investors and internally, managing VDR, preparing deliverables (presentations, budgets, models) and reports to the C-Level.